Displaying drugs 14551 - 14575 of 14852 in total
Dibromothymoquinone
At low concentrations, this compound inhibits reduction of conventional hydrophilic electron acceptors, probably acting as a plastoquinone antagonist. At higher concentrations, it acts as an electron acceptor, intercepting electrons either before or at the site of its inhibitory activity. [PubChem]
Experimental
XL019
XL019 is a selective inhibitor of the cytoplasmic tyrosine kinase JAK2. An IND for XL019 was filed by Exelixis in May 2007.
Investigational
ALS-08
ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc.
Investigational
Lauroyl chloride
Experimental
Betaine aldehyde
Experimental
2,3-Dimethyl-1,4-naphthoquinone
Experimental
Acetyl chloride
Experimental
Carphenazine
Carphenazine is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.
Withdrawn
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
Experimental
1-Amino-1-Carbonyl Pentane
Experimental
Acetophenone
Experimental
105AD7
105AD7 is a human monoclonal antibody that mimics the complement regulatory protein, CD55, overexpressed by many solid tumours including osteosarcoma. 105AD7 induced antitumour inflammatory responses in metastatic colorectal cancer patients. 105AD7 may be a suitable vaccine for treatment of this disease.
Investigational
P-Hydroxybenzaldehyde
Experimental
Acetylcysteine zidrimer
Investigational
Mebicar
Experimental
Lawsone
Experimental
Isopentyl Pyrophosphate
Experimental
Pentyl Trihydrogen Diphosphate
Experimental
Displaying drugs 14551 - 14575 of 14852 in total